Abbott GMP Investments “Pay Off” In Pharma, Despite Diagnostics Setback

Abbott's efforts to address quality control issues in the diagnostics division have had a beneficial effect on the company's GMP compliance status in pharmaceuticals, the company told a June 11 conference call

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet